Eric M. Dube - 10 Feb 2022 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Issuer symbol
TVTX
Transactions as of
10 Feb 2022
Net transactions value
-$134,523
Form type
4
Filing time
11 Feb 2022, 15:05:37 UTC
Previous filing
02 Feb 2022
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale $134,523 -4,832 -2.9% $27.84 159,913 10 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.